Mon, Sep 1, 2014, 10:10 AM EDT - U.S. Markets closed for Labor Day


% | $
Quotes you view appear here for quick access.

Graphite Corp. Message Board

robchadwick 2 posts  |  Last Activity: Aug 14, 2014 3:28 AM Member since: Feb 4, 2009
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Big insider Sale?

    by nullid2002 Aug 13, 2014 12:26 PM
    robchadwick robchadwick Aug 14, 2014 3:28 AM Flag

    10b-5-1 & not a huge % of their ownership. Stock compensation is where these execs make their money and I'm sure the plan was set up long ago. It is mentioned in their prospectus going back to 2006. This isn't news.

    Sentiment: Hold

  • UBS had a fairly intelligent coverage statement on SNSS with a Buy Rating and a price target of $14. Their analysis was pretty high level, but on point. By comparison The Street's downgrade of SNSS was an automated downgrade with no information about their pipeline and solely focused on revenue - totally inappropriate for pharmaceutical company that has not yet brought their product to market.

    UBS Coverage of SNSS:
    UBS initiated coverage on Sunesis Pharmaceuticals Inc. (NASDAQ: SNSS) with a Buy rating and a price target of $14.00.

    Analyst Andrew Peters said, "Key points from our analysis: [1] SNSS provides an exceptionally high risk/reward ahead of the ph3 VALOR read-out in 2H14. We are positively biased on the trial and see asymmetric upside on favorable data. [2] By some metrics, the current valuation implies

    Sentiment: Hold

0.0803-0.0097(-10.78%)Aug 29 10:46 AMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Criteo SA
NasdaqGSFri, Aug 29, 2014 4:00 PM EDT
Avago Technologies Limited
NasdaqGSFri, Aug 29, 2014 4:00 PM EDT